28,865 Shares in The Cooper Companies, Inc. $COO Purchased by Nykredit A S

Key Points

• Nykredit A/S acquired 28,865 shares of The Cooper Companies during the second quarter, valued at approximately $2.07 million. Institutional investors currently own 24.39% of the company.
• Cooper Companies shares opened at $69.59, below the average analyst price target of $81.64. The stock has traded between $58.89 and $89.83 over the past year and carries a high price-to-earnings ratio of 58.97.
• Analyst sentiment remains mixed, with ratings ranging from Strong Buy to Sell; the overall consensus rating is Hold. Recent targets include JPMorgan’s reduced $71 objective and Mizuho’s $85 target.

Nykredit A S acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 28,865 shares of the medical device company's stock, valued at approximately $2,070,000.

Other large investors also recently modified their holdings of the company. Avalon Trust Co bought a new position in shares of Cooper Companies during the 2nd quarter worth approximately $25,000. Root Financial Partners LLC grew its position in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. grew its position in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock valued at $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC raised its stake in Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after acquiring an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in Cooper Companies during the second quarter worth $32,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

COO stock opened at $69.59 on Tuesday. The company has a 50 day moving average price of $72.67 and a 200 day moving average price of $70.28. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock has a market capitalization of $13.57 billion, a PE ratio of 58.97, a price-to-earnings-growth ratio of 1.82 and a beta of 0.82.

Analysts Set New Price Targets

COO has been the topic of several recent analyst reports. Weiss Ratings restated a "sell (d)" rating on shares of Cooper Companies in a research note on Friday. KeyCorp reissued a "sector weight" rating on shares of Cooper Companies in a report on Friday, June 5th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Sunday, June 21st. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a "neutral" rating for the company in a report on Friday, June 5th. Finally, Mizuho set a $85.00 target price on Cooper Companies and gave the stock an "outperform" rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of "Hold" and an average target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.